These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16013358)

  • 1. Device closure of residual ventricular septal defect after repair of tetralogy of fallot using the amplatzer duct occluder.
    Vaidyanathan B; Kannan BR; Kumar RK
    Indian Heart J; 2005; 57(2):164-6. PubMed ID: 16013358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of perimembranous ventricular septal defect with amplatzer membranous occluder.
    Anil SR; Sreekanth R; Bhalerao S; Nagarajan R; Agarwal R; Girish NB
    Indian Heart J; 2005; 57(6):698-703. PubMed ID: 16521641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 28 years' experience with transatrial-transpulmonary repair of atrioventricular septal defect with tetralogy of Fallot.
    Hoohenkerk GJ; Schoof PH; Bruggemans EF; Rijlaarsdam M; Hazekamp MG
    Ann Thorac Surg; 2008 May; 85(5):1686-9. PubMed ID: 18442566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The morphologic changes of Amplatzer asymmetric ventricular septal defect occluder after transcatheter closure of perimembrane ventricular septal defect].
    Ma YT; Yang YN; Tang BP; Huang D; Mu YM; Ma X; Liu X
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):817-20. PubMed ID: 15631704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous closure of small residual ventricular septal defects after surgical repair.
    Dodge-Khatami A; Knirsch W; Tomaske M; Prêtre R; Bettex D; Rousson V; Bauersfeld U
    Ann Thorac Surg; 2007 Mar; 83(3):902-5. PubMed ID: 17307430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant aortic regurgitation associated with transcatheter closure of perimembranous ventricular septal defects with a deficient aortic rim.
    Kenny D; Tometzki A; Martin R
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):445-9. PubMed ID: 17721940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous closure of congenital and acquired ventricular septal defects--considerations on selection of the occlusion device.
    Michel-Behnke I; Le TP; Waldecker B; Akintuerk H; Valeske K; Schranz D
    J Interv Cardiol; 2005 Apr; 18(2):89-99. PubMed ID: 15882154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.
    Thanopoulos BD; Tsaousis GS; Konstadopoulou GN; Zarayelyan AG
    J Am Coll Cardiol; 1999 Apr; 33(5):1395-9. PubMed ID: 10193744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
    Pinto RJ; Dalvi BV; Sharma S
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter closure of ventricular septal defect with two different devices.
    Atik SU; Saltik L
    Cardiol Young; 2018 Nov; 28(11):1364-1366. PubMed ID: 30058512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.
    Holzer R; Balzer D; Cao QL; Lock K; Hijazi ZM;
    J Am Coll Cardiol; 2004 Apr; 43(7):1257-63. PubMed ID: 15063439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: a short-term evaluation].
    Hu HB; Jiang SL; Xu ZY; Liu YL; Lü XZ; Zhu ZH; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1592-6. PubMed ID: 15569451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous closure of ventricular septal defect associated with tunnel-shaped aneurysm using the Amplatzer duct occluder.
    Dilawar M; Numan M; El-Sisi A; Gendi SM; Ahmad Z
    Pediatr Cardiol; 2008 Mar; 29(2):366-70. PubMed ID: 17952490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter closure of congenital muscular ventricular septal defect.
    Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
    J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter closure of muscular ventricular septal defect using the Amplatzer devices.
    Djer MM; Latiff HA; Alwi M; Samion H; Kandavello G
    Heart Lung Circ; 2006 Feb; 15(1):12-7. PubMed ID: 16473785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].
    Zhao PJ; Yu ZQ; Gao W; Li F; Fu LJ; Liu TL; Li Y; Zhang YQ; Huang MR; Guo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):817-20. PubMed ID: 23302666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
    Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
    Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of perimembranous ventricular septal defect using an Amplatzer occluder--early results.
    Pawelec-Wojtalik M; Masura J; Siwińska A; Wojtalik M; Smoczyk W; Górzna-Kamińska H; Surmacz R
    Kardiol Pol; 2004 Jul; 61(7):31-40; discussion 41. PubMed ID: 15338016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricuspid valve detachment for transatrial closure of ventricular septal defects.
    Koshy S; Sunil GS; Anil SR; Dhinakar S; Shivaprakasha K; Rao SG
    Asian Cardiovasc Thorac Ann; 2002 Dec; 10(4):314-7. PubMed ID: 12538275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.
    Chessa M; Carminati M; Cao QL; Butera G; Giusti S; Bini RM; Hijazi ZM
    J Invasive Cardiol; 2002 Jun; 14(6):322-7. PubMed ID: 12042624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.